Epizyme Stock Price (NASDAQ:EPZM)

Add to My Stocks
$17.1 $0.25 (1.44%) EPZM stock closing price Feb 22, 2018 (Closing)
Prev Close* : $17.35
Market Cap:
$1.2B
Day Low: $16.95
52 Week Low: $9.30
Open: $17.5
Volume: -
Day High: $17.65
52 Week High: $20.45
Dividend:
0.00

Latest Stock Market News

Latest Articles

Epizyme News - From Partners

Another Positive Week for Stocks?   by Zacks on Sep 29, 2017

EPZM Stockcharts

View EPZM PE ratio, PS ratio stocks charts and compare with peers.
EPZM Chart
Note: Compare Epizyme stock price history with the index and industry peers.

Epizyme Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
97.74
PB ratio (
price to book ratio
)
4.98

Epizyme Returns

ROE
(return on equity)
-65%

Epizyme Financial Ratios

Asset Turnover
0
Receivables Turnover
8.36
Debt to Equity
0
Dividend Yield
0%

EPZM Industry Peers

Company Price Change (%)
Bavarian Nordic (BVNRY)12.760.9 (6.59%)
Momenta Pharma (MNTA)16.90.55 (3.36%)
Stemline Therapeutics (STML)17.61.05 (6.34%)
Kura Oncology (KURA)22.150.35 (1.56%)
Pfizer (PFE)35.740.02 (0.06%)
Merck (MRK)54.570.02 (0.04%)
Novartis (NVS)85.20.31 (0.37%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
SANGAMO THERAP (SGMO)25.43.2 (14.41%)
Clovis Oncology (CLVS)59.884.95 (9.01%)
Lexicon Pharma (LXRX)8.850.69 (8.46%)
MannKind (MNKD)2.980.22 (7.97%)
Repligen (RGEN)34.982.58 (7.96%)
Stemline Therapeutics (STML)17.61.05 (6.34%)
Fortress Biotech (FBIO)3.810.18 (4.96%)
Top gainers from Medical-Biomed-Genetics industry
* As of Feb 22, 2018
CompanyPriceChange (%)
Advaxis (ADXS)1.80.71 (28.29%)
Alkermes (ALKS)56.556.64 (10.51%)
Sorrento Therapeutics (SRNE)8.40.65 (7.18%)
Genomic Health (GHDX)31.42.08 (6.21%)
The Medicines Company (MDCO)29.831.79 (5.66%)
Catalyst Biosciences (CBIO)26.550.99 (3.59%)
EXACT Sciences (EXAS)44.991.65 (3.54%)
Top losers from Medical-Biomed-Genetics industry
* As of Feb 22, 2018

Epizyme Inc Stock News - Partner Headlines

Epizyme Gets a New CEO   on Aug 10, 2015

Epizyme Financial Statements

income statement20162015201420132012
Net Sales or Revenues8M2.56M41.41M68.48M45.22M
Net Income-110.21M-132.37M-55M-3.48M-0.7M
Total Operating Expense119.83M135.1M96.45M71.6M45.98M
View Epizyme income statement
balance sheet20162015201420132012
Total Assets252.44M217.9M199.2M162.98M103.51M
Total Liabilities50.74M48.37M38.92M58.67M154.63M
Shareholders Equity201.7M169.53M160.28M104.31M-51.12M
View Epizyme balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) in Assets Liabilities1.73M8.15M12.03M-53.77M43.28M
Net Cash from (used by) Operating Activities-96.37M-72.92M-35.36M-53.73M44.15M
Increase (Decrease) in Prop Plant And Equipment-0.62M-0.18M-2.21M-0.63M-1.48M
View Epizyme cash flow statement

Epizyme Stock Message Board

Epizyme stock lost 1.44%, and the last close price as of Feb 22, 2018 is $17.1 for EPZM stock. Stock price or share price can be used to find the total market value of a company. Epizyme market cap stands at $1.2B as of Feb 22, 2018. Epizyme valuation can be guaged using various valuation metrics like the price to earnings ratio.

The terms stocks and shares mean the same thing. For Ex: Epizyme stock price and Epizyme share price mean the same thing. The volume of shares traded stood at 196,133 on the last trading day, as is evident from Epizyme stock chart, and EPZM stock quote data. Epizyme paid 0.00 stock dividends to its shareholders during last quarter. Epizyme stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.